Summary & Overview
HCPCS J2403: Chloroprocaine HCl 3% Ophthalmic Gel, 1 mg
HCPCS Level II code J2403 designates chloroprocaine hydrochloride ophthalmic, 3% gel, 1 mg, a topical ocular anesthetic used during ophthalmic diagnostics and minor procedures. Nationally, this code matters for facility and professional billing in outpatient and ambulatory surgical settings where topical anesthesia is required, influencing coding consistency and payer coverage determinations for ocular care.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of the clinical context for use of topical ophthalmic anesthetics, payer coverage considerations, and typical sites of service. The publication summarizes benchmarking and policy-relevant topics such as code definition, common billing modifiers (listed elsewhere), and where this HCPCS Level II code fits within ophthalmology service lines.
This summary provides practitioners, coding professionals, and revenue leaders with the necessary context to identify when J2403 applies, what settings commonly use it, and which major national payers are relevant for coverage and claims submission. Data not available in the input is noted where applicable.
Billing Code Overview
HCPCS Level II code J2403 represents chloroprocaine hydrochloride ophthalmic, 3% gel, 1 mg. This code describes a topical ocular anesthetic formulation intended for ophthalmic procedures requiring local anesthesia of the eye surface. The service type is ophthalmic topical anesthesia, and the typical site of service is ambulatory surgical centers, ophthalmology clinics, and other outpatient procedural settings where topical anesthesia is applied for diagnostic or minor surgical procedures.
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A 68-year-old patient presents to an ophthalmology clinic for an in-office anterior segment procedure such as conjunctival foreign body removal, corneal abrasion debridement, or nasolacrimal duct probing where short-acting topical anesthesia is required. The clinician selects J2403 (chloroprocaine HCl ophthalmic, 3% gel, 1 mg) to provide rapid onset local anesthesia to the ocular surface. The workflow typically includes pre-procedure assessment (history, allergies, ocular exam), application of the ophthalmic gel to the affected eye(s), a brief waiting period to allow anesthesia to take effect, performance of the procedure (e.g., foreign body removal, superficial debridement, minor lid lesion repair under topical anesthesia), and post-procedure instructions including topical antibiotic or lubricating drops as indicated. Documentation includes indication, medication name and dosage (J2403), lot number and expiration, laterality if applicable, informed consent, time of application, procedural details, and any immediate adverse reaction. Typical sites of service are outpatient ophthalmology offices, ambulatory surgical centers for minor anterior segment procedures, and emergency departments for acute ocular complaints.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier — standard claim submission | Use when no special circumstance modifier applies to the service involving . |